Search Results Search Sort by RelevanceMost Recent Case and Commentary Aug 2017 Should Clinicians Medicate against Structural Violence? Potential Iatrogenic Risks and the Need for Social Interventions Lauren E. Hock, MD and Niranjan S. Karnik, MD, PhD Risks of off-label medication to treat aggression should be balanced with consequences of not responding to social factors. AMA J Ethics. 2017;19(8):753-761. doi: 10.1001/journalofethics.2017.19.8.ecas2-1708. Policy Forum Jun 2015 Veterans Health Administration Policy on Cannabis as an Adjunct to Pain Treatment with Opiates Michael Krawitz The new Veterans Health Administration policy on the use of medical marijuana was brought about by patient advocacy in 2010. AMA J Ethics. 2015;17(6):558-561. doi: 10.1001/journalofethics.2015.17.6.pfor2-1506.
Case and Commentary Aug 2017 Should Clinicians Medicate against Structural Violence? Potential Iatrogenic Risks and the Need for Social Interventions Lauren E. Hock, MD and Niranjan S. Karnik, MD, PhD Risks of off-label medication to treat aggression should be balanced with consequences of not responding to social factors. AMA J Ethics. 2017;19(8):753-761. doi: 10.1001/journalofethics.2017.19.8.ecas2-1708.
Policy Forum Jun 2015 Veterans Health Administration Policy on Cannabis as an Adjunct to Pain Treatment with Opiates Michael Krawitz The new Veterans Health Administration policy on the use of medical marijuana was brought about by patient advocacy in 2010. AMA J Ethics. 2015;17(6):558-561. doi: 10.1001/journalofethics.2015.17.6.pfor2-1506.